PUBLIC COMPANY
save$ANIPANI PHARMACEUTICALS INC
$ANIP72.18-1.07%Princeton, NJ, USupdated 1d ago
community read0 votes
pipeline
7
marketed
7
phase 3
0
catalysts ytd
5
approvals ytd
2
recalls ytd
0
Pipeline(7)
pipeline depth7 products
7Marketed
Marketed
Chewtadzy
Storage Symptoms of Benign Prostatic Hyperplasia
MarketedCortenema
Proctitis
MarketedREGLAN
Diabetic Gastroparesis
Marketedfluvoxamine maleate
Obsessive-Compulsive Disorder
Marketedlithium carbonate ER
Bipolar Disorder (Manic Depression)
Marketedsinecatechins
Genital Warts (Condylomata Acuminata)
Marketedvancocin hydrochloride
Enterocolitis
Upcoming
Recent(90d)
earnings (1)
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 13, 26SELLCook Meredith· SR. VP, GENERAL COUNSEL & SEC.−$39K↗
🐶 Hiring Signal
next earnings Nov 6, 2026
News
- Trump threatens tariffs on imported generic drugsWhile the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the specifics — prove mor…biopharma_dive · 2mo ago
Data sources
last refreshed 53m ago
Found something off?
comments(0)
5-min edit window · permanent after that